Abstract
The potent MCHR1 in vitro and in vivo antagonist activity of a series of cyclic tertiary alcohols derived from compound 2b is described. Subsequent pharmacokinetic and pharmacodynamic studies identified BMS-814580 (compound 10) as a highly efficacious antiobesity agent with a relatively clean in vitro and in vivo safety profile.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Anti-Obesity Agents / chemistry*
-
Anti-Obesity Agents / pharmacokinetics
-
Anti-Obesity Agents / pharmacology
-
Anti-Obesity Agents / therapeutic use*
-
Dogs
-
Halogenation
-
Humans
-
Macaca fascicularis
-
Male
-
Mice
-
Obesity / drug therapy*
-
Pyrimidines / chemistry*
-
Pyrimidines / pharmacokinetics
-
Pyrimidines / pharmacology
-
Pyrimidines / therapeutic use*
-
Rats
-
Receptors, Somatostatin / antagonists & inhibitors*
-
Receptors, Somatostatin / metabolism
-
Structure-Activity Relationship
Substances
-
Anti-Obesity Agents
-
MCHR1 protein, human
-
Pyrimidines
-
Receptors, Somatostatin
-
thieno(2,3-d)pyrimidine